Entera Bio Ltd. Quarterly Income Tax Expense (Benefit) in USD from Q1 2021 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Entera Bio Ltd. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q4 2023.
  • Entera Bio Ltd. Income Tax Expense (Benefit) for the quarter ending December 31, 2023 was $0.000.
  • Entera Bio Ltd. Income Tax Expense (Benefit) for the twelve months ending December 31, 2023 was $29K, a 78.8% decline year-over-year.
  • Entera Bio Ltd. annual Income Tax Expense (Benefit) for 2023 was $29K, a 78.8% decline from 2022.
  • Entera Bio Ltd. annual Income Tax Expense (Benefit) for 2022 was $137K.
  • Entera Bio Ltd. annual Income Tax Expense (Benefit) for 2021 was -$59K, a 395% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $29K $0 +$46K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 -$17K $29K -$165K -85.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $148K $0 +$4K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $144K $0 +$7K Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $137K -$46K -$31K -207% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 $168K $194K +$207K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$39K -$4K +$13K +76.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$52K -$7K +$7K +50% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 -$59K -$15K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$13K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$17K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$14K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.